Biggest News Aggregation in the World
📰 Zai Lab News

Page 34 - Zai Lab News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.

Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with... | June 6, 2023
United States Li Zhang New Hampshire United Kingdom Alina Zhang William Doyle

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Vivo Capital LLC

Vivo Capital LLC increased its holdings in Zai Lab Limited (NASDAQ:ZLAB – Get Rating) by 24.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 338,721 shares of the company’s stock after buying an additional 67,193 shares during the quarter. Zai […]
Marietta Wu Quarter For Zai Lab Proshare Advisors Ensign Peak Advisors Inc Vivo Capital Macquarie Group Ltd

Olaparib-durvalumab regimen prolongs PFS for certain women with advanced ovarian cancer

CHICAGO — First-line chemotherapy plus bevacizumab and durvalumab — followed by maintenance durvalumab, bevacizumab and olaparib — extended PFS compared with standard of care for women with non-BRCA-mutated advanced ovarian cancer.The findings of an interim analysis of the three-arm, randomized phase 3 DUO-O trial, presented at ASCO Annual Meeting, also noted a numerical
United States Devin Mclaughlin Carol Aghajanian Bymatthew Shinkle Genentech Roche Memorial Sloan Kettering Cancer Center
Source: healio.com

China Cancer Antibodies Market Trends & Clinical Trials Report 2023: Antibodies Pipeline is Still in the Expansion Phase as Global and China Drug Developers are Continuously Foraying into the Market

/PRNewswire/ -- The "China Cancer Antibodies Market Trends & Clinical Trials Insight 2023" report has been added to ResearchAndMarkets.coms offering. The...
Ascentage Pharma Immvira Pharma Akeso Biopharma Innovent Biologics Innovent Bio Gloria Biosciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science